1
Clinical Trials associated with BI-764122Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 764122 (Single-blind, Partially Randomised, Placebo-controlled, Parallel (Sequential) Group Design) and the Effect of Food on BI 764122 (Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Design) in Healthy Male Subjects
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 764122 in healthy male subjects following oral administration of single rising doses.
The objective of the food effect (FE) part is to investigate the relative bioavailability of BI 764122 under fed and fasted conditions.
100 Clinical Results associated with BI-764122
100 Translational Medicine associated with BI-764122
100 Patents (Medical) associated with BI-764122
100 Deals associated with BI-764122